Cancer, TB, vaccines included as topics in latest Call
We've launched a new Call for proposals with funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins.
Site Search
Site Search
Displaying results 281 - 290 of 893
A school for patients? Yes, you can be an expert in that
Grassroots campaigners paved the way for the modern patient advocacy movement, which is becoming increasingly sophisticated
Web search keywords can help spot early Alzheimer’s cases
Researchers from MOPEAD tested different ways to engage patients, including reaching out to suspected early Alzheimer’s sufferers by flagging internet searches like “forgetfulness”
IMI2 - Call 20
IMI2 - Call 20 was launched on 21 January 2020 with the following topics: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis Innovations to accelerate vaccine ...
Focus on: patient involvement
Patients and drug developers look at an illness from entirely different perspectives. Closing this perspective gap is one of the unmet social needs that drove the creation of IMI. Though the industry agreed for a long time that patient engagement was welcome and necessary, nobody ...
What patients really want: "Nothing about us without us”
Drug-makers have only recently started to give drug-takers a say in how their medicines are made, turning patients into a new generation of experts.
ImmUniverse
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
PET scans that show brain changes caused by Alzheimer’s give doctors confidence in diagnosis
Being able to visualise the pathology linked to the disease is a big benefit for diagnosis and patient management. Researchers from an IMI project that set out to get definitive data on the role of amyloid PET scans in Alzheimer’s disease diagnosis are hearing from physicians ...
PharmaLedger
PharmaLedger
ERA4TB
European regimen accelerator for tuberculosis